Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Biomega ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 17.9% 19.5% 11.9% 13.9% 11.4% 18.8% 18.8%   Credit score (0-100)   0 11 7 21 17 21 6 6   Credit rating   N/A B B BB BB BB B B   Credit limit (kDKK)   0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -7,517 -5,876 -6,914 -5,975 -5,355 0.0 0.0   EBITDA   0.0 -13,957 -11,916 -13,405 -13,069 -13,237 0.0 0.0   EBIT   0.0 -14,145 -13,146 -15,219 -15,662 -14,607 0.0 0.0   Pre-tax profit (PTP)   0.0 -14,173.1 -12,314.3 -16,370.6 -15,846.8 -14,693.1 0.0 0.0   Net earnings   0.0 -10,965.6 -12,314.3 -18,689.0 -15,722.5 -14,622.7 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -14,173 -12,314 -16,371 -15,847 -14,693 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Tangible assets total   0.0 488 517 1,290 1,433 804 0.0 0.0   Shareholders equity total   0.0 -10,466 -22,780 493 -1,116 -15,738 -16,552 -16,552   Interest-bearing liabilities   0.0 19,520 35,486 10,572 14,810 25,335 16,552 16,552   Balance sheet total (assets)   0.0 10,409 14,577 13,367 15,963 12,289 0.0 0.0   Net Debt   0.0 18,664 35,314 9,667 13,780 24,309 16,552 16,552     See the entire balance sheet 1000.0 Volume  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -7,517 -5,876 -6,914 -5,975 -5,355 0.0 0.0   Gross profit growth   0.0% 0.0% 21.8% -17.7% 13.6% 10.4% 0.0% 0.0%   Employees   0 14 16 15 15 16 0 0   Employee growth %   0.0% 0.0% 14.3% -6.3% 0.0% 6.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 10,409 14,577 13,367 15,963 12,289 0 0   Balance sheet change%   0.0% 0.0% 40.0% -8.3% 19.4% -23.0% -100.0% 0.0%   Added value   0.0 -13,957.3 -11,916.3 -13,404.9 -13,848.0 -13,236.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 301 831 -1,395 -3,420 -2,306 -1,205 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 -2.0 -3.0 -4.0 -5.0 0.0 0.0   1000.0 Profitability  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 188.2% 223.8% 220.1% 262.1% 272.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -67.7% -42.1% -59.9% -102.8% -64.7% 0.0% 0.0%   ROI %   0.0% -72.4% -44.5% -65.3% -119.7% -71.3% 0.0% 0.0%   ROE %   0.0% -105.3% -98.6% -248.0% -191.1% -103.5% 0.0% 0.0%   1000.0 Solidity  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Equity ratio %   0.0% -50.1% -61.0% 3.7% -6.5% -56.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -133.7% -296.3% -72.1% -105.4% -183.6% 0.0% 0.0%   Gearing %   0.0% -186.5% -155.8% 2,146.6% -1,327.4% -161.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.4% 0.2% 5.1% 1.5% 0.5% 0.0% 0.0%   1000.0 Liquidity  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Quick Ratio   0.0 0.9 0.4 0.2 0.1 0.1 0.0 0.0   Current Ratio   0.0 1.6 1.2 0.8 0.8 0.4 0.0 0.0   Cash and cash equivalent   0.0 856.5 172.0 905.4 1,030.9 1,026.8 0.0 0.0   1000.0 Capital use efficiency  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 3,695.1 1,541.5 -2,944.2 -3,212.0 -16,860.9 -8,276.0 -8,276.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2015 N/A 2016 2017/3 2017 2018/3 2018 2019/3 2019 2020/3 2020 2021/3 2021e N/A 2022e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -997 -745 -894 -923 -827 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -997 -745 -894 -871 -827 0 0   EBIT / employee   0 -1,010 -822 -1,015 -1,044 -913 0 0   Net earnings / employee   0 -783 -770 -1,246 -1,048 -914 0 0